Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Background: Ceftazidime and imipenem have been increasingly used to treat Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) due to their extended-spectrum covering Pseudomonas aeruginosa. This study aims to describe the population pharmacokinetic (PK) and pharmacodynamic (PD) tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu-Minh, Ngo, Thu-Hue, Truong, Anh-Quan, Vu, Dinh-Hoa, Le, Dinh-Chi, Vu, Ngan-Binh, Can, Tuyet-Nga, Nguyen, Hoang-Anh, Phan, Thu-Phuong, Bambeke, Françoise Van, Vidaillac, Céline, Ngo, Quy-Chau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066993/
https://www.ncbi.nlm.nih.gov/pubmed/33801657
http://dx.doi.org/10.3390/pharmaceutics13040456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066993/
https://www.ncbi.nlm.nih.gov/pubmed/33801657
http://dx.doi.org/10.3390/pharmaceutics13040456

Ejemplares similares